Identification and quantitation of interferon-gamma producing T cells in psoriatic lesions: localization to both CD4+ and CD8+ subsets.
暂无分享,去创建一个
[1] J. Voorhees,et al. Fibronectin and alpha5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin potentiation of T cell lymphokine-driven keratinocyte hyperproliferation in psoriasis. , 1998, The Journal of clinical investigation.
[2] Y. Ullmann,et al. T-lymphocyte dependence of psoriatic pathology in human psoriatic skin grafted to SCID mice. , 1997, The Journal of investigative dermatology.
[3] S. Ziegler,et al. The repertoire of T cell antigen receptor beta-chain variable regions associated with psoriasis vulgaris. , 1997, The Journal of investigative dermatology.
[4] J. Breuer,et al. Active psoriasis and profound CD4+ lymphocytopenia , 1997, The British journal of dermatology.
[5] J. Voorhees,et al. Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells. , 1997, The Journal of clinical investigation.
[6] T. Zollner,et al. Induction of psoriasiform inflammation by a bacterial superantigen in the SCID‐hu xenogeneic transplantation model , 1997, Journal of cutaneous pathology.
[7] B. Nickoloff,et al. Dermal injection of immunocytes induces psoriasis. , 1996, The Journal of clinical investigation.
[8] J. Strominger,et al. T cell subsets in normal human epidermis. , 1996, The American journal of pathology.
[9] S. Atamas,et al. An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL-4-stimulated T cell proliferation. , 1996, Journal of immunology.
[10] A. Gottlieb,et al. Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells , 1995, The Journal of experimental medicine.
[11] V. Maino,et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. , 1995, Blood.
[12] J. Voorhees,et al. Intralesional T-lymphocyte activation as a mediator of psoriatic epidermal hyperplasia. , 1995, The Journal of investigative dermatology.
[13] James G. Krueger,et al. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis , 1995, Nature Genetics.
[14] J. Voorhees,et al. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. , 1995, The Journal of clinical investigation.
[15] A. Menssen,et al. T lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells , 1994, European journal of immunology.
[16] D. Carlo,et al. CD8+ T cells in psoriatic lesions preferentially use T-cell receptor V beta 3 and/or V beta 13.1 genes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Onuma,et al. Immunohistochemical Studies of Infiltrating Cells in Early and Chronic Lesions of Psoriasis , 1994, The Journal of dermatology.
[18] W. Jochum,et al. T cells involved in psoriasis vulgaris belong to the Th1 subset. , 1994, The Journal of investigative dermatology.
[19] M. Yamamura,et al. The cytokine network in lesional and lesion-free psoriatic skin is characterized by a T-helper type 1 cell-mediated response. , 1993, The Journal of investigative dermatology.
[20] J. Voorhees,et al. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis , 1993, The Journal of experimental medicine.
[21] P. Kalinski,et al. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. , 1993, Journal of immunology.
[22] J. Garioch,et al. Group A streptococcal antigen‐specific T lymphocytes in guttate psoriatic lesions , 1993, The British journal of dermatology.
[23] D. Leung,et al. A potential role for superantigens in the pathogenesis of psoriasis. , 1993, The Journal of investigative dermatology.
[24] L. Fry,et al. The immunology of psoriasis , 1992, The British journal of dermatology.
[25] L. Fry,et al. Autoreactive proliferative responses by T-cell lines isolated from psoriatic lesions. , 1991, The Journal of investigative dermatology.
[26] O. Braun-falco,et al. Chimaeric CD4 monoclonal antibody in treatment of generalised pustular psoriasis , 1991, The Lancet.
[27] J. Voorhees,et al. Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells. , 1991, The Journal of investigative dermatology.
[28] V. Dixit,et al. Detection of interferon-gamma mRNA in psoriatic epidermis by polymerase chain reaction. , 1991, Journal of dermatological science.
[29] A. Menter,et al. Characterization of skin-infiltrating lymphocytes in patients with psoriasis. , 1991, The Journal of investigative dermatology.
[30] J. Voorhees,et al. Effects of cyclosporine on immunologic mechanisms in psoriasis. , 1990, Journal of the American Academy of Dermatology.
[31] T. Minagawa,et al. Immunohistopathologic studies in the development of psoriatic lesion influenced by gamma-interferon and the producing cells. , 1990, Journal of dermatological science.
[32] M. Duvic,et al. Immunology of AIDS related to psoriasis. , 1990, The Journal of investigative dermatology.
[33] James T. Elder,et al. UM4D4+ (CDw60) T cells are compartmentalized into psoriatic skin and release lymphokines that induce a keratinocyte phenotype expressed in psoriatic lesions. , 1990, The Journal of investigative dermatology.
[34] G. Rassner,et al. Psoriasis induced at the injection site of recombinant interferon gamma. Results of immunohistologic investigations. , 1990, Archives of dermatology.
[35] D. Macdonald,et al. T‐cell inducer populations in cutaneous inflammation: a predominance of T helper‐inducer lymphocytes (THi) in the infiltrate of inflammatory dermatoses , 1990, The British journal of dermatology.
[36] James T. Elder,et al. Decreased growth inhibition by recombinant gamma interferon is associated with increased transforming growth factor‐α production in keratinocytes cultured from psoriatic lesions , 1989, The British journal of dermatology.
[37] B. Weinshenker,et al. Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment. , 1989, Journal of the American Academy of Dermatology.
[38] J. Voorhees,et al. Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. , 1989, Journal of the American Academy of Dermatology.
[39] J. Voorhees,et al. Gamma interferon induces different keratinocyte cellular patterns of expression of HLA‐DR and DQ and intercellular adhesion molecule‐I (ICAM‐I) antigens , 1989, The British journal of dermatology.
[40] H. Valdimarsson,et al. An Altered Response by Psoriatic Keratinocytes to Gamma Interferon , 1988, Scandinavian journal of immunology.
[41] A. Gottlieb,et al. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques , 1988, The Journal of experimental medicine.
[42] H. Valdimarsson,et al. A prospective study of the Koebner reaction and T lymphocytes in uninvolved psoriatic skin. , 1988, Acta dermato-venereologica.
[43] P. Das,et al. The skin immune system (SIS): distribution and immunophenotype of lymphocyte subpopulations in normal human skin. , 1987, The Journal of investigative dermatology.
[44] J. Billings,et al. Cyclosporine improves psoriasis in a double-blind study. , 1986, JAMA.
[45] C. Griffiths,et al. Clearance of psoriasis with low dose cyclosporin. , 1986, British medical journal.
[46] H. Valdimarsson,et al. Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes. , 1986, Immunology today.
[47] C. Griffiths,et al. Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment. , 1985, Clinical and experimental immunology.
[48] E. Christophers,et al. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. , 1985, Journal of the American Academy of Dermatology.
[49] P. Biberfeld,et al. Subpopulations of mononuclear cells in microscopic lesions of psoriatic patients. Selective accumulation of suppressor/cytotoxic T cells in epidermis during the evolution of the lesion. , 1984, The Journal of investigative dermatology.
[50] T. Merigan,et al. Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes. , 1984, Laboratory investigation; a journal of technical methods and pathology.
[51] T. Merigan,et al. Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. , 1984, The Journal of investigative dermatology.
[52] H. Valdimarsson,et al. Epidermal T lymphocytes and HLA‐DR expression in psoriasis , 1984, The British journal of dermatology.
[53] W. Solbach. Brief Definitive Report TUMOR-PROMOTING PHORBOL ESTERS SELECTIVELY ABROGATE THE EXPRESSION OF THE T4 DIFFERENTIATION ANTIGEN EXPRESSED ON NORMAL AND MALIGNANT (SI),ZARY) T HELPER LYMPHOCYTES* , 2003 .
[54] V. Morhenn,et al. Expression of HLA-DR antigen in skin from patients with psoriasis. , 1982, The Journal of investigative dermatology.
[55] O. Braun-falco,et al. Initial events in psoriasis: quantitative assessment * , 1973, The British journal of dermatology.